MedPath

A clinical trial on vitiligo

Phase 2
Recruiting
Conditions
hypopigmented patches on the body
Registration Number
CTRI/2018/02/012071
Lead Sponsor
National institute of siddha
Brief Summary

It is an Open clinical trial, to evaluate the therapeutic efficacy of Mayiliragadhi chooranam internal medicine and kandangathiri ennai external medicine  from the siddha texts gunapadam thaadhu and mooligai vaguppu. Theingridients are thippili ,seeragam,mayiliragu 1gm b.i.d orally with honey for 48 days and kandankathiri pazha chaaru with olive oil external medicine. The treatment will be given for 48 days. The Laboratory investigationsand Clinical assessments will be recorded periodically before and aftertreatment period. All the trial related data will be recordered in Case ReportForm (CRF) for each patient separately. At the end of trial all the data will beanalysed statistically and the research reports will be Published

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
20
Inclusion Criteria

Age: Between 5 to 12 years Sex: Both male and female children Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body Willing to co operate for taking photographs whenever required with hisher consent.

Exclusion Criteria

1.Albinism 2.Thyroid disorder 3.Leprosy 4.HIV 5.Fungal infestation 6.Burns Patient with lesion in the lips ,sole , palm and genitalia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of the hypopigmented lesions in the affected area45 days after medications
Secondary Outcome Measures
NameTimeMethod
Reduction in the recurrence rate of the lesions.after 48 days

Trial Locations

Locations (1)

National Institute of Siddha

🇮🇳

Chennai, TAMIL NADU, India

National Institute of Siddha
🇮🇳Chennai, TAMIL NADU, India
PAlarmelmangai
Principal investigator
9677146683
eq.alarmelmangai@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.